In toxicology, understanding the anticholinergic burden is critical for predicting and managing potential adverse effects of medications, especially in vulnerable populations like the elderly. Many commonly prescribed drugs have anticholinergic properties, and their cumulative effect can lead to significant cognitive decline, increasing the risk of dementia, delirium, and other cognitive disorders. Toxicologists can use the ACB scale to evaluate the risk and develop strategies for minimizing adverse outcomes.
